Trinity Biotech plc
TRIB · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $61 | $52 | $62 | $57 |
| - Cash | $2 | $4 | $5 | $3 |
| + Debt | $113 | $108 | $101 | $94 |
| Enterprise Value | $172 | $156 | $158 | $148 |
| Revenue | $11 | $8 | $16 | $15 |
| % Growth | 44.8% | -52.2% | 4.7% | – |
| Gross Profit | $4 | $2 | $5 | $5 |
| % Margin | 39.5% | 20.7% | 30.8% | 35% |
| EBITDA | -$3 | -$6 | -$10 | -$1 |
| % Margin | -26.7% | -77.2% | -60.5% | -7.3% |
| Net Income | -$6 | -$9 | -$17 | -$5 |
| % Margin | -55.1% | -116.2% | -106.9% | -31.4% |
| EPS Diluted | -0.32 | -0.48 | -1.2 | -0.46 |
| % Growth | 33.3% | 60% | -160.9% | – |
| Operating Cash Flow | -$2 | -$3 | $3 | -$4 |
| Capital Expenditures | -$0 | -$0 | -$3 | -$3 |
| Free Cash Flow | -$2 | -$3 | $1 | -$6 |